The THOR IDE Study
NCT: NCT05916950 · RECRUITING
Brief Summary
The goal of this clinical trial is to test the Thor system in adult (≥ 18 year old) patients with de novo (new, never treated) calcified lesions in infrainguinal (leg) arteries (peripheral artery disease or PAD). The main question\[s\] it aims to answer are: * Is the Thor system safe in treating these lesions * Does the Thor system work to treat these lesions Participants will: * Receive treatment with the Thor system * Have follow-up visits at Discharge, 30 days, 6 months, and 12 months
Frequently Asked Questions
What is The THOR IDE Study?
The THOR IDE Study is a clinical trial registered under NCT05916950. Current status: RECRUITING.
What is the status of NCT05916950?
The current status of NCT05916950 (The THOR IDE Study) is: RECRUITING.
When did The THOR IDE Study start?
The THOR IDE Study started on 2024-10-29.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.